For You
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point
Specialty:
Multispecialty
Allergy & Immunology
Anesthesiology
Business of Medicine
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Medical Students
Nurses
Pharmacists
Residents
Today on Medscape
Edition:
ENGLISH
DEUTSCH
ESPAÑOL
FRANÇAIS
PORTUGUÊS
Log In
Sign Up It's Free!
Edition:
ENGLISH
DEUTSCH
ESPAÑOL
FRANÇAIS
PORTUGUÊS
Register
Log In
No Results
No Results
Saturday, April 17, 2021
For You
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point
close
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.
Log out
Cancel
From
Medscape Oncology
Medscape Medical News from the
American Society of Hematology (ASH) 56th Annual Meeting
December 06 - 09, 2014; San Francisco, California
Meeting Highlights at a Glance
Top News From ASH 2014: Slideshow
Practice-changing studies and exciting preliminary research highlighted this year's meeting in San Francisco.
Conference News
ASH
CAR T-cells Are Durable, Drive Pediatric ALL Away
Medscape Medical News
, December 18, 2014
ASH
An All-Oral Therapy Tested in Multiple Myeloma
Medscape Medical News
, December 17, 2014
ASH
87% Complete Remission Rate With Nilotinib in ALL
Medscape Medical News
, December 17, 2014
ASH
Solutions Needed to Stem Cancer Costs, ASH Experts Say
Medscape Medical News
, December 16, 2014
ASH
LMWH Best for VTEs in Cancer, But There's a Catch in US
Medscape Medical News
, December 16, 2014
ASH
No Chemo: Agent Represents a 'New Way of Thinking About AML'
Medscape Medical News
, December 16, 2014
ASH
ASH Unveils Second Choosing Wisely List
Medscape Medical News
, December 15, 2014
ASH
New Study on Incidental Pulmonary Embolism and Cancer
Medscape Medical News
, December 11, 2014
ASH
Novel Agent Reduces Need for Transfusion in MDS
Medscape Medical News
, December 11, 2014
ASH
Factor XI Inhibitor Cuts VTE Risk in Orthopedic Surgery
Heartwire from Medscape
, December 9, 2014
ASH
Tailored Treatment Boosts Prognosis in High-Risk T-cell ALL
Medscape Medical News
, December 9, 2014
ASH
Tangle in AML: Is VALOR 'Crummy' or the 'New Standard'?
Medscape Medical News
, December 9, 2014
ASH
First Top-flight Evidence of TKI Benefit in AML
Medscape Medical News
, December 8, 2014
ASH
Treat Young Adults With ALL as Children for Better Outcomes
Medscape Medical News
, December 8, 2014
ASH
Experimental Antibodies Target Multiple Myeloma
Medscape Medical News
, December 8, 2014
ASH
Blinatumomab Eradicates Minimal Residual Disease in ALL
Medscape Medical News
, December 7, 2014
ASH
Practice-Changing Study in HIV-Related Lymphoma
Medscape Medical News
, December 7, 2014
ASH
First-Time Finding in Posttransplant Hodgkin Lymphoma
Medscape Medical News
, December 6, 2014
ASH
'Unprecedented Results' in Relapsed Multiple Myeloma
Medscape Medical News
, December 6, 2014
ASH
PD-1 Blockade Arrives in Hematologic Cancer
Medscape Medical News
, December 6, 2014
ASH
What's Hot at 2014 ASH
Medscape Medical News
, November 25, 2014
Medscape Oncology© WebMD, LLC
Oncology Insights
The Future of Hodgkin Lymphoma -- Brentuximab and Beyond
Bruce D. Cheson, MD; Ann S. LaCasce, MD, MSc
CLL: It's the Best -- and Most Confusing -- of Times
Bruce D. Cheson, MD; Susan M. O'Brien, MD
Double-Hit Lymphomas Explained, With Surprising EPOCH-R Data
Bruce D. Cheson, MD;
Andrew D. Zelenetz, MD, PhD
R-squared Update: Underwhelms in FL, but Impressive in MCL
Bruce D. Cheson, MD; Nathan H. Fowler, MD
Myeloma Update -- Part 1: Carfilzomib and Panobinostat
Sagar Lonial, MD; Gabriel Miller
Myeloma Update -- Part II: ASPIRE, STRATUS, and New Antibodies
Paul G. Richardson, MD; Gabriel Miller
Pre-Meeting Expert Commentary
ASH 2014: If You're Going to San Francisco...
Bruce D. Cheson, MD
Previous Coverage
ASH 55th Annual Meeting
ASH 54th Annual Meeting
ASH 53rd Annual Meeting